Analyst firms · Canaccord Genuity · DOCS
Canaccord Genuity DOCS price target and rating history
Doximity Inc. (DOCS) · Technology
Canaccord Genuity rates Doximity Inc. (DOCS) Buy with a $34 price target, as of its latest action on Feb 9, 2026. It has published 4 rating actions on DOCS since July 2021, including 1 upgrade and 1 downgrade. Across 11 firms with a DOCS price target in the last 12 months, the median target is $25. Canaccord Genuity's $34 is 36% above that.
- Current rating
- Buy
- Price target
- $34
- Median target, all firms
- $25
- Actions on DOCS
- 4
Canaccord Genuity price target on DOCS
Every Canaccord Genuity rating on DOCS
- Feb 9, 2026
- Nov 13, 2024
- Nov 10, 2021
- Jul 19, 2021
How other firms rate DOCS
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wells Fargo | Underweight | $18 | Aug 10, 2026 |
| BofA Securities | Underperform | $20 | Jun 29, 2026 |
| Barclays | Equal Weight | $20 | May 15, 2026 |
| KeyBanc Capital Markets | Sector Weight | May 14, 2026 | |
| Robert W. Baird | Neutral | $18 | May 14, 2026 |
| BTIG | Neutral | May 14, 2026 | |
| Jefferies | Hold | $19 | May 14, 2026 |
| Truist Securities | Hold | $29 | Apr 20, 2026 |
| Evercore ISI | In-line | $25 | Apr 8, 2026 |
| Canaccord Genuity | Buy | $34 | Feb 9, 2026 |
| RBC Capital Markets | Outperform | $59 | Jan 9, 2026 |
| Morgan Stanley | Overweight | $65 | Dec 15, 2025 |
| Raymond James | Strong Buy | $65 | Nov 21, 2025 |
Questions about Canaccord Genuity and DOCS
- What is Canaccord Genuity's price target for DOCS?
- Canaccord Genuity's latest stated price target for Doximity Inc. (DOCS) is $34, from its action on Feb 9, 2026.
- What is Canaccord Genuity's rating on DOCS?
- Canaccord Genuity rates DOCS Buy, a bullish rating, as of Feb 9, 2026.
- When did Canaccord Genuity last change its view on DOCS?
- On Feb 9, 2026, Canaccord Genuity upgrades to Buy from Hold, price target $34.
- How does Canaccord Genuity's DOCS target compare with other analysts?
- Across 11 firms with a DOCS price target in the last 12 months, the median target is $25. Canaccord Genuity's $34 is 36% above that.
More DOCS rating histories
- Wells Fargo7
- BofA Securities6
- Barclays4
- KeyBanc Capital Markets3
- Robert W. Baird3
- BTIG3
- Jefferies3
- Truist Securities3
- Evercore ISI3
- Morgan Stanley8
- Raymond James5
- Goldman Sachs6
- Piper Sandler4
- Leerink Partners4
- Needham6
- J.P. Morgan4
- Guggenheim3
All Canaccord Genuity ratingsDOCS news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.